• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 4. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate (CAS No. 1187236-18-5): A Versatile Building Block in Modern Pharmaceutical Chemistry

Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate (CAS No. 1187236-18-5) is a highly valuable intermediate in the realm of pharmaceutical chemistry, renowned for its structural versatility and functional adaptability. This compound, featuring a brominated imidazo[1,2-a]pyridine core, has garnered significant attention in recent years due to its role as a key precursor in the synthesis of various biologically active molecules. The presence of both a bromine substituent and a carboxylate ester group provides a unique platform for further chemical modifications, making it an indispensable tool for medicinal chemists exploring novel therapeutic agents.

The imidazo[1,2-a]pyridine scaffold is a privileged structure in drug discovery, known for its ability to interact with multiple biological targets. Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate leverages this advantage by offering a reactive handle at the 7-position bromine atom and the 2-carboxylate moiety. These functional groups are particularly useful for constructing complex heterocyclic frameworks through cross-coupling reactions such as Suzuki-Miyaura, Buchwald-Hartwig, and Stille couplings. Furthermore, the carboxylate ester can be hydrolyzed to the corresponding carboxylic acid or converted into other derivatives like amides or acids, expanding its synthetic utility.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting cancer-related kinases and other therapeutic enzymes. The brominated imidazo[1,2-a]pyridine core has been extensively explored in this context, with several compounds showing promising preclinical activity. For instance, derivatives of this scaffold have demonstrated efficacy against tyrosine kinases such as EGFR, ALK, and TRK. The bromine atom at the 7-position serves as an excellent site for palladium-catalyzed cross-coupling reactions, enabling the introduction of diverse aryl and heteroaryl groups that can modulate binding affinity and selectivity.

The carboxylate ester group in Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate also plays a crucial role in medicinal chemistry applications. It can be readily transformed into other functional groups through various chemical transformations. For example, hydrolysis under basic conditions yields the corresponding carboxylic acid, which can then be further modified via esterification or amidation to introduce additional pharmacophoric elements. This flexibility makes it an ideal candidate for library synthesis and high-throughput screening programs aimed at identifying novel drug candidates.

Advances in computational chemistry have further enhanced the utility of Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate. Molecular modeling studies have revealed that the brominated imidazo[1,2-a]pyridine scaffold can effectively engage with biological targets through hydrogen bonding networks and hydrophobic interactions. The presence of the bromine atom at the 7-position allows for fine-tuning of binding affinity by influencing electronic and steric properties. Additionally, virtual screening techniques have been employed to identify potential hits based on their alignment with known active compounds in databases.

The synthesis of Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate typically involves multi-step organic transformations starting from commercially available precursors. A common synthetic route includes the condensation of 2-amino benzaldehyde with glyoxal to form an imidazolone intermediate, which is subsequently brominated at the 7-position using appropriate brominating agents. The resulting 7-bromoimidazole is then coupled with methyl acrylate via esterification to yield the desired product. This approach highlights the compound's accessibility and scalability for industrial applications.

The growing interest in immunomodulatory agents has also contributed to the relevance of Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate. Imidazo[1,2-a]pyridines have been reported to exhibit immunostimulatory properties by interacting with pattern recognition receptors such as Toll-like receptors (TLRs). Derivatives of this scaffold have shown potential in modulating immune responses against infectious diseases and cancer. The bromine atom provides a handle for further derivatization to fine-tune immunological activity while maintaining structural integrity.

In conclusion, Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate (CAS No. 1187236-18-5) represents a cornerstone in modern pharmaceutical chemistry due to its multifaceted utility as a building block for drug discovery. Its unique structural features enable diverse chemical modifications while maintaining high reactivity and biological relevance. As research continues to uncover new therapeutic applications for imidazo[1,2-a]pyridines and related scaffolds, Ethyl 7-bromoimidazo[1,2-a]pyridine-2-carboxylate is poised to remain an essential component in the armamentarium of medicinal chemists worldwide.

• 67625-37-0(Ethyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 69707-18-2(ethyl imidazo[2,1-a]isoquinoline-2-carboxylate)
• 38922-77-9(Ethyl imidazo[1,2-a]pyridine-2-carboxylate)
• 123531-52-2(Ethyl imidazo1,2-apyridine-3-carboxylate)
• 81438-56-4(Ethyl 6-Bromo-2-Methylimidazo1,2-APyridine-3-Carboxylate)
• 135995-45-8(Ethyl 8-bromo-5-methylimidazo1,2-apyridine-2-carboxylate)
• 354548-08-6(Methyl 6-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 1038393-19-9(ethyl 8-bromoimidazo[1,2-a]pyridine-2-carboxylate)
• 1019018-46-2(7-bromoimidazo1,2-apyridine-2-carboxylic acid)
• 372198-69-1(Ethyl 6-bromoimidazo[1,2-a]pyridine-3-carboxylate)